Eravacycline (ERV) has emerged as a therapeutic option for the treatment of carbapenem-resistant pathogens. However, the advent of heteroresistance (HR) to ERV poses a challenge to these therapeutic s
Comparative genomics and transcriptomics to identify genetic mechanisms underlying the emergence of carbapenem resistant Acinetobacter baumannii (CRAb)